Difference between revisions of "Lugli A, et al. Br. J. Cancer (2010) cited as Ref 702 in DOI: 10.1038/s41392-020-0110-5 (Q9965)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created claim: Published In Name String (P102): Br. J. Cancer, #quickstatements; #temporary_batch_1590006349955)
(‎Created claim: Page(s) (P105): 382-390, #quickstatements; #temporary_batch_1590074839150)
 
(2 intermediate revisions by the same user not shown)
Property / Volume
 +
103
Property / Volume: 103 / rank
 +
Normal rank
Property / title
 +
Prognostic impact of the expression of putative cancer stem cell markers CD133 CD166 CD44s EpCAM and ALDH1 in colorectal cancer (English)
Property / title: Prognostic impact of the expression of putative cancer stem cell markers CD133 CD166 CD44s EpCAM and ALDH1 in colorectal cancer (English) / rank
 +
Normal rank
Property / Page(s)
 +
382-390
Property / Page(s): 382-390 / rank
 +
Normal rank

Latest revision as of 15:49, 21 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Lugli A, et al. Br. J. Cancer (2010) cited as Ref 702 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Lugli A
    0 references
    0 references
    2010
    0 references
    Br. J. Cancer
    0 references
    103
    0 references
    Prognostic impact of the expression of putative cancer stem cell markers CD133 CD166 CD44s EpCAM and ALDH1 in colorectal cancer (English)
    0 references
    382-390
    0 references